| [1] Tang D C,Zhang J,Toro H,et al.Adenovirus as a carrier for the development of influenza virus-free avian influenza vaccines[J].Expert Rev Vaccines,2009,8(4):469-481.[2] Chan P K S.Outbreak of avian influenza A (H5N1) virus infection in Hong Kong in 1997[J].Clinical Infectious Diseases,2002,34(2):S58-S64.[3] Pascua P N Q,Choi Y K.Zoonotic infections with avian influenza A viruses and vaccine preparedness:A game of "mix and match"[J].Clin Exp Vaccine Res,2014,3(2):140-148.[4] Nichol K L,Treanor J J.Vaccines for seasonal and pandemic influenza[J].Journal of Infectious Diseases,2006,194(2):S111-S118.[5] Hoyert D L,Kung H C,Smith B L.Deaths:Preliminary data for 2003[J].Natl Vital Stat Rep,2005,53(15):1-48.[6] Podewils L J,Liedtke L A,McDonald L C,et al.A national survey of severe influenza-associated complications among children and adults,2003—2004[J].Clin Infect Dis,2005,40(11):1693-1696.[7] Fire A E,Uyeki T M,Broder K,et al.Prevention and control of influenza with vaccines:Recommendations of the Advisory Committee on Immunization Practices (ACIP),2010[J].MMWR Morb Mortal Wkly Rep, 2010,59(RR-8):1-62.[8] Tripp R A,Tompkins S M.Virus-vectored influenza virus vaccines[J]. Viruses,2014,6(8):3055-3079.[9] 刘志刚,刘立峰,陈伦勇,等.禽流感新型疫苗研究进展[J].动物医学进展,2013,2:99-103.[10] Moss B.Reflections on the early development of poxvirus vectors[J].Vaccine,2013,31(39):4220-4222.[11] Panicali D,Paoletti E.Construction of poxviruses as cloning vectors:Insertion of the thymidine kinase gene from herpes simplex virus into the DNA of infectious vaccinia virus[J].Proc Natl Acad Sci USA,1982,79(16):4927-4931.[12] Mackett M,Smith G L,Moss B.Vaccinia virus:A selectable eukaryotic cloning and expression vector[J].Proc Natl Acad Sci USA,1982,79(23):7415-7419.[13] Smith G L,Murphy B R,Moss B.Construction and characterization of an infectious vaccinia virus recombinant that expresses the influenza hemagglutinin gene and induces resistance to influenza virus infection in hamsters[J].Proc Natl Acad Sci USA,1983,80(23):7155-7159.[14] Smith G L,Levin J Z,Palese P,et al.Synthesis and cellular location of the ten influenza polypeptides individually expressed by recombinant vaccinia viruses[J].Virology,1987,160(2):336-345.[15] Bublot M,Pritchard N,Swayne D E,et al.Development and use of fowlpox vectored vaccines for avian influenza[J].Ann N Y Acad Sci,2006,1081(1):193-201.[16] Minke J M,Audonnet J C,Fischer L.Equine viral vaccines:The past,present and future[J].Veterinary Research,2004,35(4):425-443.[17] Qiao C,Yu K,Jiang Y,et al.Protection of chickens against highly lethal H5N1 and H7N1 avian influenza viruses with a recombinant fowlpox virus co-expressing H5 haemagglutinin and N1 neuraminidase genes[J].Avian Pathology,2003,32(1):25-31.[18] 乔传玲.表达禽流感病毒 HA-NA、HA-NP 及 NP 基因重组禽痘病毒的构建及其免疫效力的研究[D].北京:中国农业科学院,2001.[19] Bertran K,Sá E Silva M,Pantin-Jackwood M J.Protection against H7N3 high pathogenicity avian influenza in chickens immunized with a recombinant fowlpoxand an inactivated avian influenza vaccines[J].Vaccine,2013,31(35):3572-3576.[20] Ge J,Deng G,Wen Z,et al.Newcastle disease virus-based live attenuated vaccine completely protects chickens and mice from lethal challenge of homologous and heterologous H5N1 avian influenza viruses[J].J Virol,2007,81(1):150-158.[21] 王 伟.表达 H5N1 禽流感病毒HA基因重组腺病毒的构建及免疫保护性研究[D].哈尔滨:东北农业大学,2013.[22] 乔传玲,于康震,贾永清,等.表达H5亚型禽流感病毒血凝素和神经氨酸酶双基因重组禽痘病毒的构建[J].中国预防兽医学报,2000,22(S1):45-46.[23] Liu G,Zhang F,Shi J,et al.A subunit vaccine candidate derived from a classic H5N1 avian influenza virus in China protects fowls and BALB/c mice from lethal challenge[J].Vaccine,2013,31(46):5398-5404.[24] Kodihalli S,Sivanandan V,Nagaraja K V,et al.A type-specific avian influenza virus subunit vaccine for turkeys:Induction of protective immunity to challenge infection[J].Vaccine,1994,12(15):1467-1472.[25] 李 贺.H7 亚型禽流感基因工程亚单位疫苗的研究[D].乌鲁木齐:新疆农业大学,2006.[26] 张新涛.禽流感病毒 M2e 亚单位疫苗的研究[D].北京:中国农业科学院,2010.[27] 冯书营,董仕桢,张树逍.H5N1亚型禽流感病毒疫苗的研究现状及应用前景[J].中国畜牧兽医,2013,40(9):208-213.[28] Ulmer J B,Donnelly J J,Parker S E,et al.Heterologous protection against influenza by injection of DNA encoding a viral protein[J].Science,1993,259(5102):1745-1749.[29] Yamazaki T,Ichinohe T.Inflammasomes in antiviral immunity:Clues for influenza vaccine development[J].Clin Exp Vaccine Res,2014,3(1):5-11.[30] Sasaki S,Takeshita F,Xin K Q,et al.Adjuvant formulations and delivery systems for DNA vaccines[J].Methods,2003,31(3):243-254.[31] 宋 涛,胡建和,杭柏林.禽流感疫苗的研究现状[J].中国畜牧兽医,2010,37(5):178-180.[32] 张强哲.H5亚型禽流感病毒HA DNA疫苗的研究[D].杨凌:西北农林科技大学,2003.[33] Drape R J,Macklin M D,Barr L J,et al.Epidermal DNA vaccine for influenza is immunogenic in humans[J].Vaccine,2006,24(21):4475-4481.[34] Park K S,Seo Y B,Lee J Y,et al.Complete protection against a H5N2 avian influenza virus by a DNA vaccine expressing a fusion protein of H1N1 HA and M2e[J].Vaccine,2011,29(33):5481-5487.[35] Macklin M D,McCabe D,McGregor M W,et al.Immunization of pigs with a particle-mediated DNA vaccine to influenza A virus protects against challenge with homologous virus[J].J Virol,1998,72(2):1491-1496.[36] Chen H,Yu K,Jiang Y,et al.DNA immunization elicits high HI antibody and protects chicken from AIV challenge[A].International Congress Series[C].Elsevier,2001.[37] 戈胜强,王志亮.禽流感病毒样颗粒研究进展[J].病毒学报,2013,29(2):224-232.[38] Kost T A,Condreay J P,Jarvis D L.Baculovirus as versatile vectors for protein expression in insect and mammalian cells[J].Nature Biotechnology,2005,23(5):567-575.[39] 王立强,许 龙,周晓巍,等.应用HA、NA、M1 和 M2蛋白制备H5N1高致病性禽流感病毒样颗粒[J].生物技术通讯,2012,22(6):759-763.[40] 黄晓媛,施金荣,韩锡鑫,等.H5N1重组禽流感病毒样颗粒免疫原性研究[J].微生物学免疫学进展,2013,1:7-11.[41] Pushko P,Tumpey T M,Bu F,et al.Influenza virus-like particles comprised of the HA,NA,and M1 proteins of H9N2 influenza virus induce protective immune responses in BALB/c mice[J].Vaccine,2005,23(50):5751-5759. |
